bioRxiv · 29 Aug 2026 · Preprint

Tumour-derived glucocorticoids amplify ROR1 and are exploited with glucocorticoid-resistant ROR1 CAR-T cells

Schauer, Weber + 15 more

3 cites

Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's.

The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.

Read the brief in JClub →

Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial.
The Lancet Oncology · 1 Aug 2026 · Randomized Controlled Trial
Baseline use of proton pump inhibitors and antibiotics significantly reduces progression-free and overall survival in unresectable stage III NSCLC patients treated with durvalumab, with hazard ratios up to 1.66.
- Open access
- 7 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42398520
Open in JClub

Journals this month

All journals →

Moving areas, week to 3 Oct 2026

All research areas →

Read